{"id":479735,"date":"2021-04-21T09:18:25","date_gmt":"2021-04-21T13:18:25","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\/"},"modified":"2021-04-21T09:18:25","modified_gmt":"2021-04-21T13:18:25","slug":"ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\/","title":{"rendered":"Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Business Update"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n ENGLEWOOD, Colo.<\/span>, April 21, 2021<\/span> \/PRNewswire\/ —\u00a0Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced it will host a conference call to discuss financial results for the quarter ended March 31, 2021<\/span> and provide a corporate business update on Wednesday, May 5, 2021<\/span> at 4:30pm EDT<\/span>\/ 2:30pm MT<\/span>.<\/p>\n

\n

\n
\n \"Ampio
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n\n\n\n\n\n\n
\n

\n
\n
\n Conference Call & Webcast:<\/u>
\n <\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Wednesday, May 5, 2021, 4:30pm EDT \/ 2:30pm MT<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Domestic:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 888-506-0062 – Conference ID# 268913<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n International: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n 973-528-0011 – Conference ID# 268913<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n Webcast Link:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n https:\/\/www.webcaster4.com\/Webcast\/Page\/2569\/40836<\/a>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

The conference call will also be available from the Investor Relations section of the Company’s website at www.ampiopharma.com<\/a>\u00a0and will be archived there shortly after the live event.<\/p>\n

\n About Ampio Pharmaceuticals<\/b>\n <\/p>\n

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company primarily focused on the advancement of immunology-based therapies to treat prevalent inflammatory conditions for which there are limited treatment options. Ampio’s lead drug, Ampion, is backed by an extensive patent portfolio with intellectual property protection extending through 2035 and will be eligible for 12-year FDA market exclusivity upon approval as a novel biologic under the biologics price competition and innovation act (BPCIA).<\/p>\n

\n Forward Looking Statements<\/b>\n <\/p>\n

Ampio’s statements in this press release that are not historical fact, and that relate to future plans or events, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of words such as “believe,” “expect,” “plan,” “anticipate,” and similar expressions. These forward-looking statements include statements regarding Ampio’s expectations with respect to\u00a0Ampion and its classification, as well as those associated with regulatory approvals and other FDA decisions, the Biological License Application (BLA), the ability of Ampio to enter\u00a0\u00a0into partnering arrangements, \u00a0clinical trials and decisions and changes in business conditions and similar events, the ability to receive regulatory approval to conduct clinical trials, that Ampion may be used to treat ARDS induced by COVID-19, all of which are inherently subject to various risks and uncertainties. The risks and uncertainties involved include those detailed from time to time in Ampio’s filings with the Securities and Exchange Commission, including without limitation, under Ampio’s Annual Report on Form 10-K and other documents filed with the Securities and Exchange Commission. Ampio undertakes no obligation to revise or update these forward-looking statements, whether as a result of new information, future events or otherwise.<\/p>\n

\n Company Contacts<\/b>\u00a0
<\/b>Investor Relations\u00a0
<\/b>Joe Hassett\u00a0
joeh@gregoryfca.com<\/a>\u00a0
484-686-6600<\/p>\n

\n Media Contact\u00a0
<\/b>Katie Kennedy\u00a0\u00a0
katiek@gregoryfca.com<\/a>\u00a0
610-731-1045<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update-301273698.html<\/a><\/p>\n

SOURCE Ampio Pharmaceuticals, Inc.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire ENGLEWOOD, Colo., April 21, 2021 \/PRNewswire\/ —\u00a0Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced it will host a conference call to discuss financial results for the quarter ended March 31, 2021 and provide a corporate business update on Wednesday, May 5, 2021 at 4:30pm EDT\/ 2:30pm MT. Conference Call & Webcast: Wednesday, May 5, 2021, 4:30pm EDT \/ 2:30pm MT Domestic:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 888-506-0062 – Conference ID# 268913 International: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 973-528-0011 – Conference ID# 268913 Webcast Link:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 https:\/\/www.webcaster4.com\/Webcast\/Page\/2569\/40836 The conference call will also be available from the Investor Relations section of the Company’s website at www.ampiopharma.com\u00a0and will be archived there shortly after the live event. About Ampio … <\/p>\n

Continue reading “Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Business Update”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-479735","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nAmpio Pharmaceuticals, Inc. to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Business Update - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Business Update - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire ENGLEWOOD, Colo., April 21, 2021 \/PRNewswire\/ —\u00a0Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced it will host a conference call to discuss financial results for the quarter ended March 31, 2021 and provide a corporate business update on Wednesday, May 5, 2021 at 4:30pm EDT\/ 2:30pm MT. Conference Call & Webcast: Wednesday, May 5, 2021, 4:30pm EDT \/ 2:30pm MT Domestic:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 888-506-0062 – Conference ID# 268913 International: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 973-528-0011 – Conference ID# 268913 Webcast Link:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 https:\/\/www.webcaster4.com\/Webcast\/Page\/2569\/40836 The conference call will also be available from the Investor Relations section of the Company’s website at www.ampiopharma.com\u00a0and will be archived there shortly after the live event. About Ampio … Continue reading "Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Business Update"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-21T13:18:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/479965\/Ampio_Pharmaceuticals_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Business Update\",\"datePublished\":\"2021-04-21T13:18:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\\\/\"},\"wordCount\":444,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/479965\\\/Ampio_Pharmaceuticals_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\\\/\",\"name\":\"Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Business Update - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/479965\\\/Ampio_Pharmaceuticals_Logo.jpg\",\"datePublished\":\"2021-04-21T13:18:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/479965\\\/Ampio_Pharmaceuticals_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/479965\\\/Ampio_Pharmaceuticals_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Business Update\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Business Update - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\/","og_locale":"en_US","og_type":"article","og_title":"Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Business Update - Market Newsdesk","og_description":"PR Newswire ENGLEWOOD, Colo., April 21, 2021 \/PRNewswire\/ —\u00a0Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced it will host a conference call to discuss financial results for the quarter ended March 31, 2021 and provide a corporate business update on Wednesday, May 5, 2021 at 4:30pm EDT\/ 2:30pm MT. Conference Call & Webcast: Wednesday, May 5, 2021, 4:30pm EDT \/ 2:30pm MT Domestic:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 888-506-0062 – Conference ID# 268913 International: \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 973-528-0011 – Conference ID# 268913 Webcast Link:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 https:\/\/www.webcaster4.com\/Webcast\/Page\/2569\/40836 The conference call will also be available from the Investor Relations section of the Company’s website at www.ampiopharma.com\u00a0and will be archived there shortly after the live event. About Ampio … Continue reading \"Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Business Update\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-21T13:18:25+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/479965\/Ampio_Pharmaceuticals_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Business Update","datePublished":"2021-04-21T13:18:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\/"},"wordCount":444,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/479965\/Ampio_Pharmaceuticals_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\/","name":"Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Business Update - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/479965\/Ampio_Pharmaceuticals_Logo.jpg","datePublished":"2021-04-21T13:18:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/479965\/Ampio_Pharmaceuticals_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/479965\/Ampio_Pharmaceuticals_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ampio-pharmaceuticals-inc-to-report-fiscal-2021-first-quarter-financial-results-and-provide-corporate-business-update\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Business Update"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/479735","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=479735"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/479735\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=479735"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=479735"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=479735"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}